It worries me that you had the same idea. Do you think this would be legal? A CEO of one company sets up another company, sells his company to the new company, and then moves to the new company as CEO. This is sort of like screwing it forward. The fact that Stoll isn't quashing it, and Varney isn't responding gives this thing some credence. Newman-Tancredi operates out of France, and the only pharma with a stake in corx right now is Servier, which has a bad reputation in france, where they face charges of fraud: http://www.latribune.fr/entreprises-finance/industrie/chimie-pharmacie/20110926trib000651801/en-attendant-son-proces-servier-rassure-ses-employes-.html